David Risinger
Stock Analyst at Leerink Partners
(4.98)
# 56
Out of 4,495 analysts
1098
Total ratings
65%
Success rate
33.4%
Average return
Main Sectors:
Stocks Rated by David Risinger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,232 | $1,227.74 | +0.35% | 119 | Jun 25, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | n/a | $82.30 | - | 15 | Jun 2, 2026 | |
| ANAB AnaptysBio | Reiterated: Buy | n/a | $66.01 | - | 33 | May 27, 2026 | |
| REGN Regeneron Pharmaceuticals | Downgraded: Hold | $641 | $664.59 | -3.55% | 58 | May 18, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $201 → $265 | $266.22 | -0.46% | 53 | May 15, 2026 | |
| IMA ImageneBio | Maintained: Buy | $30 → $24 | $5.93 | +305.06% | 2 | May 8, 2026 | |
| TRAX First Tracks Biotherapeutics | Initiated Coverage: Buy | $46 | $20.77 | +121.47% | 1 | Apr 24, 2026 | |
| XOMA XOMA Royalty | Maintained: Buy | $50 | $44.89 | +11.38% | 19 | Feb 24, 2026 | |
| AMGN Amgen | Maintained: Hold | n/a | $367.99 | - | 42 | Jan 13, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $60 | $57.73 | +3.94% | 71 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $253.27 | - | 72 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $78.86 | - | 37 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 | $509.80 | +2.98% | 44 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $75.37 | - | 58 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $32 | $36.09 | -11.33% | 47 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $24.23 | +7.31% | 90 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $57.57 | - | 27 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $17.06 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $43.06 | - | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $35.50 | - | 13 | Sep 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.84 | - | 5 | Aug 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 | $16.99 | -23.48% | 21 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $44 | $54.57 | -19.36% | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $27 → $23 | $74.46 | n/a | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $53.00 | n/a | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.77 | n/a | 1 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $42.17 | n/a | 1 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 | $135.82 | n/a | 12 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.99 | n/a | 1 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $33 | $13.50 | n/a | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $176 | $245.72 | n/a | 12 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $20 → $22 | $32.52 | n/a | 15 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $125.55 | n/a | 34 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $16 | $16.52 | n/a | 24 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $45 | $10.64 | n/a | 19 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $49.71 | $6.96 | n/a | 32 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $22 | $53.90 | n/a | 19 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 → $9 | $33.04 | n/a | 29 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $41 | $24.39 | n/a | 8 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $167 → $174 | $75.59 | n/a | 16 | Nov 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $51 | $58.48 | n/a | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $3 | $16.73 | n/a | 4 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $308.98 | n/a | 2 | Nov 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $140.57 | n/a | 3 | Sep 21, 2012 |
Eli Lilly and Company
Jun 25, 2026
Maintained: Buy
Price Target: $1,232
Current: $1,227.74
Upside: +0.35%
Oruka Therapeutics
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $82.30
Upside: -
AnaptysBio
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $66.01
Upside: -
Regeneron Pharmaceuticals
May 18, 2026
Downgraded: Hold
Price Target: $641
Current: $664.59
Upside: -3.55%
Johnson & Johnson
May 15, 2026
Reiterated: Buy
Price Target: $201 → $265
Current: $266.22
Upside: -0.46%
ImageneBio
May 8, 2026
Maintained: Buy
Price Target: $30 → $24
Current: $5.93
Upside: +305.06%
First Tracks Biotherapeutics
Apr 24, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $20.77
Upside: +121.47%
XOMA Royalty
Feb 24, 2026
Maintained: Buy
Price Target: $50
Current: $44.89
Upside: +11.38%
Amgen
Jan 13, 2026
Maintained: Hold
Price Target: n/a
Current: $367.99
Upside: -
Bristol-Myers Squibb Company
Jan 13, 2026
Maintained: Buy
Price Target: $60
Current: $57.73
Upside: +3.94%
Jan 13, 2026
Maintained: Buy
Price Target: n/a
Current: $253.27
Upside: -
Jan 8, 2026
Maintained: Hold
Price Target: n/a
Current: $78.86
Upside: -
Dec 29, 2025
Maintained: Buy
Price Target: $525
Current: $509.80
Upside: +2.98%
Dec 24, 2025
Maintained: Buy
Price Target: n/a
Current: $75.37
Upside: -
Dec 15, 2025
Reiterated: Buy
Price Target: $22 → $32
Current: $36.09
Upside: -11.33%
Dec 9, 2025
Maintained: Hold
Price Target: $26
Current: $24.23
Upside: +7.31%
Oct 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $57.57
Upside: -
Sep 17, 2025
Maintained: Buy
Price Target: n/a
Current: $17.06
Upside: -
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $43.06
Upside: -
Sep 1, 2025
Maintained: Buy
Price Target: n/a
Current: $35.50
Upside: -
Aug 17, 2025
Reiterated: Buy
Price Target: n/a
Current: $7.84
Upside: -
Aug 13, 2025
Maintained: Hold
Price Target: $13
Current: $16.99
Upside: -23.48%
Aug 7, 2025
Maintained: Buy
Price Target: $60 → $44
Current: $54.57
Upside: -19.36%
Apr 16, 2025
Maintained: Sell
Price Target: $27 → $23
Current: $74.46
Upside: n/a
Feb 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $53.00
Upside: n/a
Jan 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.77
Upside: n/a
May 1, 2024
Reiterated: Buy
Price Target: n/a
Current: $42.17
Upside: n/a
Apr 28, 2023
Maintained: Hold
Price Target: $91
Current: $135.82
Upside: n/a
Mar 14, 2023
Maintained: Buy
Price Target: n/a
Current: $10.99
Upside: n/a
Jun 11, 2021
Initiated Coverage: Hold
Price Target: $33
Current: $13.50
Upside: n/a
May 21, 2021
Reiterated: Hold
Price Target: $176
Current: $245.72
Upside: n/a
May 13, 2021
Maintained: Sell
Price Target: $20 → $22
Current: $32.52
Upside: n/a
Apr 1, 2021
Maintained: Buy
Price Target: $90
Current: $125.55
Upside: n/a
Mar 10, 2021
Maintained: Hold
Price Target: $18 → $16
Current: $16.52
Upside: n/a
Mar 5, 2021
Maintained: Hold
Price Target: $53 → $45
Current: $10.64
Upside: n/a
Feb 26, 2021
Maintained: Hold
Price Target: $49.71
Current: $6.96
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $16 → $22
Current: $53.90
Upside: n/a
Dec 21, 2020
Maintained: Sell
Price Target: $8 → $9
Current: $33.04
Upside: n/a
Nov 23, 2020
Maintained: Buy
Price Target: $31 → $41
Current: $24.39
Upside: n/a
Nov 13, 2020
Maintained: Hold
Price Target: $167 → $174
Current: $75.59
Upside: n/a
Jul 13, 2020
Initiated Coverage: Hold
Price Target: $51
Current: $58.48
Upside: n/a
Apr 2, 2020
Maintained: Hold
Price Target: $18 → $3
Current: $16.73
Upside: n/a
Nov 16, 2015
Upgraded: Hold
Price Target: n/a
Current: $308.98
Upside: n/a
Sep 21, 2012
Maintained: Buy
Price Target: $36
Current: $140.57
Upside: n/a